You might not see us during your visit to Huntsman Cancer Institute (HCI), but we want to let you know that we are working hard in the Varley Lab in the HCI research building next door. We conduct research that improves the treatment and care of patients like you. We are a small group of dedicated young men and women who are developing new strategies to diagnose and treat breast and ovarian cancer.
Cancer Research Posts
For National Cancer Control Month, Bridget Grahmann, BS, and Yelena Wu, PhD, of The Wu Team at Huntsman Cancer Institute (HCI) explain what cancer control is and how it helps people with cancer as well as those who may never have it.
Clinical trials for some cancer patients may be the last, best hope for survival. A phase I trial is the first time a treatment is studied in people—usually a select number of patients who have not had success with other treatments. A rigorous process of approval takes place before doctors test these new therapies on patients for the first time.
Inheriting a mutation in the APC gene leads to a nearly 100% lifetime risk of colorectal cancer. While colon cancer can be kept at bay by removing the large intestine, these patients also have up to a 15% risk of getting cancer in the small intestine, which is the leading cause of cancer death in this patient group. A new study published in the Journal of the American Medical Association (JAMA) has identified the first prevention treatment for these patients, a two-drug combination that significantly reduces the number and size of precancerous polyps in the small intestine.
Have you ever wondered what research happens at Huntsman Cancer Institute (HCI) below the Point restaurant? Hundreds of researchers are working together every day to learn more about cancer and find better ways to support patients and families.